top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations
Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations
Autore Ruaro Barbara
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (178 p.)
Soggetto topico Medicine
Pharmacology
Soggetto non controllato systemic sclerosis
scleroderma
interstitial lung disease
pulmonary function tests
high-resolution computed tomography
rheumatic
pulmonary arterial hypertension
targeted therapy
systemic lupus erythematosus
airway disease
shrinking lung syndrome
diffuse alveolar hemorrhage
pleurisy
infection
cardiopulmonary exercise testing
osteopontin
connective tissue diseases
pulmonary involvement
microvascular involvement
nailfold capillaroscopy
rheumatoid arthritis
interstitial lung diseases
CX3CL1/fractalkine
CX3CR1
M1 macrophage
M2 macrophage
SKG mice
heart failure
3D-echocardiography
ventricular function
outcome
ventricular-arterial coupling
antifibrotic agents
COVID-19
IPF
progressive fibrosing ILD
UIP
pharmacological interactions
fibromyalgia
gastrointestinal symptoms
probiotic
VSL#3®
efficacy
tolerability
polymyalgia rheumatica
vagus nerve stimulation
inflammatory response
PMR
t-vns
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Rheumatic Diseases
Record Nr. UNINA-9910566486303321
Ruaro Barbara  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Rheumatoid Arthritis Therapy Reappraisal : Strategies, Opportunities and Challenges
Rheumatoid Arthritis Therapy Reappraisal : Strategies, Opportunities and Challenges
Autore Müller Rüdiger
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (260 p.)
Soggetto topico Medicine
Soggetto non controllato rheumatoid arthritis
sleep
sleep disorders
pain
osteoporosis
fracture
fracture risk assessment tool
treat-to-target
certolizumab pegol
csDMARDs
glucocorticoids
intra-articular injections
DAS 28
ACR response
HAQ-DI
TNFα
golimumab
efficacy
tolerability
immunogenicity
methotrexate
posology
titration
oral route
subcutaneous route
bioavailability
effectiveness
periodontitis
periodontal disease
anti-citrullinated protein autoantibodies
rheumatoid factor
smoking
medication
Porphyromonas gingivalis
Rheumatoid arthritis
matrix metalloproteinase 3
infliximab
pharmacogenomics
anti-TNF
personalized medicine
baricitinib
disease-modifying antirheumatic drugs
pain perception
outcomes research
patient perspective
Rheumatoid Arthritis
therapy
DMARD
MTX
Tumor Necrosis Factor-Alpha Inhibitors
ankylosing spondylitis
biosimilar
switching
synovial fibroblasts
cytokine
osteoclast
herbal medicine
methylation
next-generation sequencing
recovery of function
fatigue
productivity
tofacitinib
oral
Th1.17
IL-17A
IFN-γ, CD73
adenosine
psoriatic arthritis
regulation
pseudoerosions
hand
foot
ultrasonography
radiography
computed tomography
magnetic resonance imaging
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Rheumatoid Arthritis Therapy Reappraisal
Record Nr. UNINA-9910557286503321
Müller Rüdiger  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui